Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hers vs NovoCare Pharmacy

Hers
Graded #252

Higher grade

vs+8.699999999999996
NovoCare Pharmacy
Graded #442

Lower grade

The verdict

Hers takes it — 63.9/100 to 55.2/100.

Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHers +30
54
24
Dose & formulationHers +11
77
66
Clinical oversightNovoCare Pharmacy +3
71
74
Labs & monitoringHers +1
52
51
FulfillmentHers +5
81
76
Contract termsNovoCare Pharmacy +14
41
55
Hers · left barNovoCare Pharmacy · right bar

The numbers

MetricHersNovoCare Pharmacy
WeighScore63.9/10055.2/100
GradeCC
Scorecard rank#252#442
Semaglutide$199/mo (starting dose, compounded)$349/mo (2.4 mg dose, brand-name)
Tirzepatide$299/mo (starting dose, plus a separate fee, brand-name)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Hers

Graded #252 · C

Strengths

  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
NovoCare Pharmacy

Graded #442 · C

Strengths

  • First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
  • $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
  • $349/mo standard self-pay is well below the ~$1,300/mo retail list price
  • Ships to all 50 states with no telehealth-platform middleman fees
  • Cold-chain logistics handled directly by Novo Nordisk

Where it loses points

  • Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
  • Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
  • No clinical support included — your own prescriber handles titration and side effects
  • Manufacturer-set pricing can change at any time
  • $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard